Cargando…

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

BACKGROUND: Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H(1)-antihistam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Karsten, Maurer, Marcus, Grattan, Clive, Nakonechna, Alla, Abuzakouk, Mohamed, Bérard, Frédéric, Sussman, Gordon, Giménez-Arnau, Ana M., Ortiz de Frutos, Javier, Knulst, André, Canonica, G. Walter, Hollis, Kelly, McBride, Doreen, Balp, Maria-Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538755/ https://www.ncbi.nlm.nih.gov/pubmed/26284152 http://dx.doi.org/10.1186/s13601-015-0072-9

Ejemplares similares

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU
por: Maurer, M., et al.
Publicado: (2017)

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU
por: Sussman, G., et al.
Publicado: (2018)

Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study
por: Hollis, Kelly, et al.
Publicado: (2018)

Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
por: Balp, Maria-Magdalena, et al.
Publicado: (2021)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
por: Lima, Hermenio, et al.
Publicado: (2017)

EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
por: Hawe, Emma, et al.
Publicado: (2016)

Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)()
por: Jang, Jae-Hyuk, et al.
Publicado: (2022)

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014)

Assessing Changes in Chronic Spontaneous/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling
por: Stull, Donald E., et al.
Publicado: (2016)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria()
por: Metz, Martin, et al.
Publicado: (2022)

Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria
por: Kocatürk, Emek, et al.
Publicado: (2017)

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria
por: Bernstein, Jonathan A., et al.
Publicado: (2023)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)

Is chronic urticaria more than skin deep?
por: Kocatürk, Emek, et al.
Publicado: (2019)

Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study
por: Grieco, Teresa, et al.
Publicado: (2022)

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
por: Sella, Juliana A., et al.
Publicado: (2023)

Suppression of Basophil FcεRI Activation by Serum from Active Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Subjects
por: Sterba, Patricia M, et al.
Publicado: (2015)

Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
por: Krause, Karoline, et al.
Publicado: (2023)

Resistant Chronic Spontaneous Urticaria – A Case Series Narrative Review of Treatment Options
por: Khan, Sujoy, et al.
Publicado: (2022)

Neutral Dietary Effects of Two MicroRNAs, Csu-Novel-260 and Csu-Mir-14, on the Non-Target Arthropod Folsomia candida
por: Zhou, Qinli, et al.
Publicado: (2023)

Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review
por: Wong, Melanie Mitsui, et al.
Publicado: (2020)

What Basophil Testing Tells Us About CSU Patients – Results of the CORSA Study
por: Marcelino, João, et al.
Publicado: (2021)

Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
por: Asero, Riccardo, et al.
Publicado: (2023)

Management of urticaria: not too complicated, not too simple
por: Ferrer, M, et al.
Publicado: (2015)

Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies
por: Gimenéz-Arnau, Ana M., et al.
Publicado: (2016)

Contact Urticaria Syndrome: a Comprehensive Review
por: Giménez-Arnau, Ana M., et al.
Publicado: (2022)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test()
por: Brzoza, Zenon, et al.
Publicado: (2022)

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A
por: Lobna, Matanis, et al.
Publicado: (2021)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
por: Casale, Thomas B., et al.
Publicado: (2023)

Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
por: Jauregui, Ignacio, et al.
Publicado: (2019)

Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
por: Kolkhir, Pavel, et al.
Publicado: (2021)

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
por: Maurer, Marcus, et al.
Publicado: (2020)

Burden of chronic urticaria relative to psoriasis in five European countries
por: Balp, M.M., et al.
Publicado: (2017)

Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria
por: Finlay, A.Y., et al.
Publicado: (2017)

Chronic urticaria in most patients is poorly controlled: Results of the development, validation, and real life application of the arabic urticaria control test
por: Irani, Carla, et al.
Publicado: (2017)

The Burden of Chronic Urticaria from Brazilian Patients’ Perspective
por: Balp, Maria-Magdalena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mbspol5ftf6caso2t28fa30b0k